First, we tested pretreatment with VEN on AML cells (with VEN subsequently washed off) followed by WT1-CTL co-culture, modeling a clinical scenario in which VEN is given to a patient followed by CTL infusion 24 h afterward. Here, WT1 is linked to acute myeloid leukemia.